Summary • Verrica Pharmaceuticals (VRCA) dropped 11% in pre-market trading to $6.72, with no new catalysts driving the move.• The company recently announced a $50 million private placement to retire ...
Summary • Kyverna Therapeutics (KYTX) shares fell 7% pre-market to $10.04 following a public offering announcement.• The company proposed a $100 million offering, with an additional $15 million option ...
Summary • Trinseo PLC’s stock rises 9% to $0.6000 in pre-market trading amid NYSE compliance concerns.• The NYSE issued a ...
Summary • Ryde Group Ltd. (RYDE) shares rose 9% pre-market to 0.4800 following the announcement of strategic expansion into ...
Summary • Pulse Biosciences, Inc (PLSE) shares rise 8.8% in pre-market trading, reaching $15.37.• The company initiates a research collaboration with MD Anderson Cancer Center to explore its nPulse™ ...
Summary • Gain Therapeutics, Inc. (GANX) rose 6.8% in pre-market trading to $4.22 without a clear catalyst.• The stock shows strong momentum with a 14-day RSI of 67.32 and substantial annual growth of ...
Summary • AMC Robotics Corporation (AMCI) shares surged 33.8% in pre-market trading, rising to $9.73.• The spike follows the ...
Summary • Genius Group Limited (GNS) shares climbed 5.5% in pre-market trading, raising prices to $0.6990 without a clear catalyst.• A class action lawsuit for alleged securities fraud has been filed, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback